CapsCanada, a Windsor, Ontario, Canada-headquartered provider of capsules for pharmaceuticals and dietary supplements, has invested $28 million to add a new 100,000-square-foot manufacturing facility for hydroxypropyl methylcellulose (HPMC) capsules. With this investment, CapsCanada has increased capsule output by 50%.

Produced with 100% plant-derived material, CapsCanada’s K-CAPS are designed for consumers with dietary restrictions that prohibit the consumption of animal by-products. They are suitable for a range of formulations. K-CAPS are sold in more than 60 countries worldwide.

CapsCanada is a manufacturer of HPMC capsules for a variety of applications, including those that are liquid, hygroscopic, or otherwise sensitive to moisture. The company previously made a $10-million expansion of its Windsor, Ontario site in 2014.

Source: CapsCanada